Answers are grounded in this paper and cite their sources.
Cefepime is used for the treatment of nosocomial infections and serves as a carbapenem-sparing agent for treating AmpC inducible bacteria. Cefepime induced neurotoxicity (CIN) is a well-documented adverse effect, although data describing the risk of CIN in patients with a history of seizures (HOS) remains limited.
No takes yet. Share an insight, caveat, or question.
Baalbaki et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: